Back to guides

Mounjaro 5 mg: Dose, Side Effects and Profile

Discreet next day delivery
100% UK-based pharmacy
Free advice and support
We're rated 4.7 out of 5
Mounjaro 5 mg once weekly is the first step up from the 2.5 mg starting dose, reached after four weeks. It is also the lowest recommended maintenance dose, so some people stay on it long term. In the weight management trials, nausea at 5 mg was reported by around 24.6 percent of people, mostly mild to moderate. It is a prescription-only medicine assessed individually.
Mounjaro 5 mg is the dose most people meet first after their starting month, and it raises a lot of practical questions: is it a real treatment dose or just a step on the way up, what side effects come with it, and how long might you stay on it. The answers are clearer than the marketing around different strengths suggests.

This guide covers the 5 mg dose specifically: where it sits in the schedule, how you reach it, the side effects reported at this strength, and what to discuss with your prescriber. It draws on the UK Summary of Product Characteristics, the NHS and NICE.

What the 5 mg dose is and where it sits

Mounjaro comes in six strengths, from 2.5 mg to 15 mg, each delivered as a 0.6 ml dose from a pre-filled KwikPen 4. The 5 mg pen delivers 5 mg of tirzepatide per weekly dose 4. It is the second dose in the schedule, the one you move to after four weeks on the 2.5 mg starting dose 1.

Importantly, 5 mg is also one of the three recommended maintenance doses, alongside 10 and 15 mg 1. The 2.5 mg dose, by contrast, is a starting dose meant to build tolerance rather than a maintenance dose. So 5 mg is the lowest strength at which the SmPC expects people might settle for ongoing treatment 1.

That distinction matters: reaching 5 mg is not necessarily a staging post to a higher dose. For some people 5 mg, tolerated well alongside diet and activity, is where they stay. Our Mounjaro dose guide sets out the full schedule.

At 5 mg the medicine is working in the same way it does at any strength: tirzepatide is a dual GIP and GLP-1 receptor agonist that reduces hunger, increases fullness and slows how quickly the stomach empties 7. The dose influences how strong those effects are and how likely side effects become, but the mechanism is the same 7. That is why some people get a meaningful response at 5 mg without needing to climb higher.

How you reach 5 mg

The SmPC schedule is fixed at the start: 2.5 mg once weekly for four weeks, then an increase to 5 mg once weekly 1. The 2.5 mg month exists to let your body adjust and to reduce the gastrointestinal side effects that are most common early on 1.

After 5 mg, if more weight loss is needed and the dose is tolerated, further increases can be made in 2.5 mg steps after a minimum of four weeks at the current dose, up to a maximum of 15 mg 1. But there is no obligation to climb. The aim is the lowest dose that works for you, not the highest. Our article on why side effects sometimes return when you increase the dose explains what to expect if you do step up.

You inject 5 mg once a week, on the same day where you can, at any time of day, with or without food, rotating the injection site 1. If you miss a dose, you can take it within four days; otherwise skip it and resume your usual day 1.

Side effects at 5 mg

The side effects at 5 mg are the familiar gastrointestinal ones: nausea, diarrhoea, vomiting, constipation and abdominal pain 2. In the pooled weight management trials, at the 5 mg dose nausea was reported by about 24.6 percent of people and overall gastrointestinal disorders by about 55.6 percent, compared with 8.5 and 29.7 percent on placebo 2. Most reactions were mild or moderate and decreased over time 2.

The proportion of people who stopped treatment permanently because of a gut side effect at 5 mg in the weight management trials was about 1.9 percent, the lowest of the doses studied 2. That fits the general pattern that side effects, and discontinuation for them, tend to rise with dose 2.

Other reported effects, not specific to 5 mg, include decreased appetite, dizziness, injection site reactions, a small rise in heart rate, and hair loss 2. Our full side effects guide and advice on managing nausea and constipation cover the practical side.

The serious risks that apply at any strength apply at 5 mg too, even though it is the lowest maintenance dose. The SmPC reports acute pancreatitis as an uncommon reaction and asks anyone with persistent, severe abdominal pain to seek immediate medical attention, and it cautions about gallbladder problems and dehydration from the gut effects 3. A lower dose does not remove these; it is one reason 5 mg, like every strength, is prescription-only and assessed individually 1.

At 5 mg (weight management trials)Figure
Nausea~24.6% vs 8.5% placebo 2
Any gastrointestinal disorder~55.6% vs 29.7% placebo 2
Stopped due to a gut side effect~1.9% vs 0.5% placebo 2
Dose positionSecond dose in the schedule; lowest maintenance dose 1
Considering treatment for weight management? You can start an assessment with a Cloud Pharmacy clinician, who will review your medical history and confirm whether treatment is appropriate.

Is 5 mg a maintenance dose?

Yes. The SmPC lists the recommended maintenance doses as 5, 10 and 15 mg1. That means 5 mg is a legitimate long-term dose, not merely a step you must move beyond. Whether you stay at 5 mg or go higher depends on how you are responding and how you tolerate it, which is a clinical judgement 1.

NICE uses a six-month checkpoint, looking for at least 5 percent weight loss on the highest tolerated dose, to decide whether treatment is working 5. If 5 mg is your highest tolerated dose and it is delivering, that is a valid place to be. If it is not enough and you tolerate more, a higher dose is an option to discuss.

It is worth resisting the assumption that a higher number is automatically better. The recommended maintenance doses, 5, 10 and 15 mg, are options along a range, and the right one is the lowest that gives you a good response with tolerable side effects 1. Side effects and the chance of stopping for them tend to rise with dose, so settling at an effective 5 mg can be a better outcome than pushing to a higher dose you tolerate less well 2.

What to expect in the first weeks at 5 mg

Moving to 5 mg from the 2.5 mg starting dose is the first real dose increase, so it is a moment when side effects can be more noticeable again, then settle. The SmPC notes that gut side effects peak around dose escalation and decrease over time 2, so a few days of stronger nausea after stepping up to 5 mg is common and usually eases.

On the appetite side, the effect builds rather than switching on at once. The SmPC reports reduced hunger from the first week of treatment and increased fullness from around week three 7, and at a maintenance dose like 5 mg that effect is steadier than during the first build-up. Many people notice they are full sooner and less drawn to snacks.

Weight change is gradual and individual, and 5 mg is a genuine treatment dose rather than just a stepping stone, so it is worth giving it time before assuming it is not enough 1. Our guide on how long Mounjaro takes to work sets out realistic timelines.

What to discuss with your prescriber

If you are on or moving to 5 mg, useful things to raise include how you are tolerating it, whether your side effects are settling, and whether staying at 5 mg or increasing makes sense for you 1. If you take a sulphonylurea or insulin for diabetes, the dose of those may need adjusting to reduce the risk of low blood sugar 3.

It is also worth flagging the interactions that apply at any dose. Tirzepatide can reduce the absorption of the contraceptive pill, so the SmPC advises a barrier or non-oral method for four weeks at the start and after each dose increase 8. It can slow the absorption of other oral medicines too, so tell your prescriber and pharmacist what else you take 8. And it must not be used in pregnancy 8.

On cost, different strengths can be priced differently on the private market, but a guide like this does not quote prices; what shapes the cost is covered separately, and the clinical decision should lead, not the price tag. Whatever the strength, only ever obtain Mounjaro from a registered pharmacy after a clinical assessment 6.

Frequently asked questions

Is Mounjaro 5 mg a starting dose?

No. The starting dose is 2.5 mg once weekly for four weeks; 5 mg is the next step after that 1. It is also the lowest of the three recommended maintenance doses (5, 10 and 15 mg), so some people stay on 5 mg long term rather than moving higher 1.

What are the side effects of Mounjaro 5 mg?

Mainly gastrointestinal. In the weight management trials, nausea at 5 mg was reported by around 24.6 percent of people and any gut disorder by about 55.6 percent, mostly mild to moderate and easing over time 2. About 1.9 percent stopped because of a gut side effect, the lowest of the studied doses 2.

How long do you stay on Mounjaro 5 mg?

There is no fixed time. Because 5 mg is a recommended maintenance dose, some people stay on it long term, while others increase in 2.5 mg steps after at least four weeks if more weight loss is needed and it is tolerated 1. NICE reviews progress at six months on the highest tolerated dose 5. It is a clinical decision with your prescriber.

Can I stay on 5 mg instead of going higher?

Yes, if it is working for you and tolerated, because 5 mg is one of the recommended maintenance doses 1. The aim is the lowest effective dose, not the highest. If 5 mg is your highest tolerated dose and you are meeting the six-month checkpoint of at least 5 percent weight loss, that is a valid place to stay 5.

Does Mounjaro 5 mg work differently from higher doses?

The mechanism is the same at every strength: tirzepatide reduces hunger, increases fullness and slows stomach emptying as a dual GIP and GLP-1 receptor agonist 7. The dose affects how strong the effects are and how likely side effects become, not how it works 7. Some people respond well at 5 mg without needing to increase 1.

Are the serious risks lower at 5 mg?

The serious risks are not removed by being on the lowest maintenance dose. The SmPC's cautions about acute pancreatitis, gallbladder problems and dehydration apply at 5 mg as at any strength, and persistent, severe abdominal pain needs immediate medical attention 3. Gut side effects and discontinuation for them are somewhat less common at 5 mg than higher doses, but the safety cautions are the same 23.

Your next step

Mounjaro 5 mg is both the first step up from the starting dose and the lowest recommended maintenance dose, so it can be a destination rather than just a staging post. Its side effects are the usual gut ones, generally milder than at higher doses, and most settle over time, while the serious cautions apply at this dose just as at any other.

If you are on or approaching 5 mg, talk to your prescriber about how you are tolerating it and whether staying or increasing makes sense for you. Only obtain Mounjaro from a registered pharmacy, report any side effects through the Yellow Card scheme, and remember that the contraceptive and oral-medicine interactions apply at this dose as at any other.

Disclaimer

This guide is for general information only and does not constitute medical advice, diagnosis or treatment. The information here describes general clinical context based on UK regulatory sources cited above; it is not a recommendation for any specific medicine or treatment, which can only be made by a prescriber following individual assessment.

If you are considering treatment, speak to your GP or pharmacist, or arrange a consultation with a Cloud Pharmacy clinician. Prescription-only medicines are issued only after clinical assessment and where appropriate.

If you experience side effects from any medicine, you can report them through the Yellow Card scheme at yellowcard.mhra.gov.uk.

References

  1. 4.2 Posology (Mounjaro 5 mg)
  2. 4.8 Undesirable effects (weight management, 5 mg)
  3. 4.4 Special warnings (pancreatitis, gallbladder, dehydration, hypoglycaemia)
  4. 2 Composition
  5. 1 Recommendations (6-month review)
  6. Tirzepatide, registered pharmacy
  7. 5.1 Pharmacodynamic properties (mechanism)
  8. 4.5 Interactions / 4.6 pregnancy

Author Information

All of our medication and condition content is written by UK qualified pharmacists and doctors.

Anna Wedderburn

Authored by

Anna Wedderburn

Clinical Director

Nazmul Kadir

Reviewed by

Nazmul Kadir

Director & Superintendent Pharmacist

GPhC Number: 2215377

Review Date16 June 2026
Next Review16 June 2027
Published on16 June 2026
Last Update16 June 2026

Start your free weight loss consultation

Complete our online questionnaire so our clinical team can check eligibility for the desired treatment.

  • Takes less than 5 minutes to complete
  • Reviewed by our UK-based medical team
  • Approved treatments dispatched same day (before 3pm)
Anna Wedderburn

Anna Wedderburn

Clinical Director

Need something else?

We stock over 1102 treatments for 90 conditions